Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ROIV - Arbutus Biopharma: The Markman Win Is A Good Milestone But Uncertainty Remains

ROIV - Arbutus Biopharma: The Markman Win Is A Good Milestone But Uncertainty Remains

Roivant Sciences Ltd.

2024-04-10 04:22:17 ET

Summary

  • Arbutus Biopharma and Roivant won a crucial claims construction ruling in their patent infringement lawsuit against Moderna.
  • The ruling opens the way for a potential total win against Moderna, but uncertainties remain regarding the lawsuit and Arbutus' pipeline.
  • The potential litigation payout could be significant, but the company's expensive pipeline development and cash burn rate are concerns.

...

For further details see:

Arbutus Biopharma: The Markman Win Is A Good Milestone But Uncertainty Remains
Stock Information
Company Name: Roivant Sciences Ltd.
Stock Symbol: ROIV
Market: NASDAQ
Website: roivant.com
Menu
ROIV ROIV Quote ROIV Short ROIV News ROIV Articles ROIV Message Board
Get ROIV Alerts

News, Short Squeeze, Breakout and More Instantly...